Retinitis pigmentosa is a group of inherited eye diseases characterized by the gradual degeneration of photoreceptor cells in the retina. This causes vision loss that gets worse over time, with symptoms including trouble seeing at night and developing tunnel vision. It is a genetic disorder, where mutations in any of several genes can cause the photoreceptor cells to deteriorate. The progression and severity of vision loss varies between individuals. While there is no cure, treatments aim to slow the progression and help manage symptoms through methods like vitamin supplements, sunglasses, low vision aids, and retinal implants.
Pigmentary glaucoma - Dr Shylesh B DabkeShylesh Dabke
Pigment Dispersion Syndrome (PDS) involves abnormal amounts of pigment released from the iris that deposit throughout the eye. It can sometimes progress to Pigmentary Glaucoma (PG). PDS is more common in young, white, myopic males and has genetic links. Theories for its pathogenesis include mechanical abrasion between the iris and lens zonules or abnormal iris cell degeneration. Over time, PDS can cause increased eye pressure and vision loss from PG if not properly treated with medications, laser procedures, or surgery.
This document discusses various types of ischemic optic neuropathy (ION). It begins by introducing ION as a major cause of vision loss and outlines its classification into anterior and posterior forms. It then details the anatomy and vascular supply of the optic nerve, risk factors for ION such as nocturnal blood pressure changes, and the pathogenesis involving hypoperfusion and axonal swelling. Non-arteritic anterior ION is described as the most common type, while posterior ION and arteritic forms are less prevalent but can involve vascular inflammation. The document outlines signs, investigations, management approaches including steroids, and variable prognoses for the different ION types.
This document discusses the evaluation of the nasolacrimal system. It covers the history and anatomy of the system, classification of epiphora, diagnostic tests used to evaluate the system including anatomical tests like syringing and probing, functional tests like dye disappearance tests, and secretory tests like Schirmer's test. The document also discusses differentiating anatomical obstruction from functional/physiological causes of excessive tearing and localization of blockages in the system.
This document provides an overview of myopia, including its definition, global epidemiology, risk factors, management options, and the importance of controlling axial length growth. It discusses that myopia prevalence is increasing globally and poses lifelong risks. Risk factors for increased myopia progression include younger age, family history, near work, ethnicity, and binocular vision issues. The document reviews behavioral, optical, and pharmacological management strategies and their effectiveness, noting that controlling axial length growth through approaches like orthokeratology and atropine is key to managing myopia progression.
Pseudoexfoliation glaucoma is a type of secondary glaucoma caused by the buildup of fibrillar protein deposits in the eye. It is the most common cause of secondary glaucoma worldwide and can lead to rapid progression of optic nerve damage. Risk factors include being over 50 years old, female gender, and living in northern latitudes. Signs include white flake deposits on the iris and lens that obstruct aqueous outflow, raising intraocular pressure and risk of vision loss from glaucoma if not treated.
This document discusses the classification and management of exotropia. Exotropia is an outward deviation of the visual axis and can be classified as primary, consecutive, secondary, or residual. Primary exotropia is further classified as intermittent or constant. Intermittent exotropia is present when the deviation is intermittently manifest and can be further classified as intermittent distance exotropia or intermittent near exotropia. Conservative treatment includes orthoptic exercises and optical measures like prisms or tinted glasses. Surgical treatment, such as lateral rectus recession or resection procedures, may be considered if conservative treatment is insufficient to control the deviation.
Vitreous hemorrhage occurs when blood leaks into the vitreous cavity in the eye. It can be caused by abnormal blood vessels like those seen in proliferative diabetic retinopathy, tears or detachment of the retina, trauma, or tumors. Patients experience symptoms like decreased vision and floaters. Examination may reveal an absent red reflex or old yellow vitreal hemorrhage. Management depends on the underlying cause and includes observation, laser treatment if the retina can be visualized, vitrectomy if the view is obscured or treatment can't be delivered, and anti-VEGF drugs to reduce neovascularization until laser can be performed.
Retinitis pigmentosa is a slow degenerative, hereditary disease of the retina that involves the rods and cones. It typically appears as a recessive trait due to consanguinity of the parents. Patients experience night blindness in childhood, tunnel vision or central visual loss in middle age, and complete blindness in advanced age. Physical examination shows black spots resembling bone corpuscles across the retina, extremely attenuated retinal blood vessels, and pale optic discs, indicating optic nerve atrophy. There is no specific treatment currently available, but cataract surgery and rehabilitation services can help manage complications.
Pigmentary glaucoma - Dr Shylesh B DabkeShylesh Dabke
Pigment Dispersion Syndrome (PDS) involves abnormal amounts of pigment released from the iris that deposit throughout the eye. It can sometimes progress to Pigmentary Glaucoma (PG). PDS is more common in young, white, myopic males and has genetic links. Theories for its pathogenesis include mechanical abrasion between the iris and lens zonules or abnormal iris cell degeneration. Over time, PDS can cause increased eye pressure and vision loss from PG if not properly treated with medications, laser procedures, or surgery.
This document discusses various types of ischemic optic neuropathy (ION). It begins by introducing ION as a major cause of vision loss and outlines its classification into anterior and posterior forms. It then details the anatomy and vascular supply of the optic nerve, risk factors for ION such as nocturnal blood pressure changes, and the pathogenesis involving hypoperfusion and axonal swelling. Non-arteritic anterior ION is described as the most common type, while posterior ION and arteritic forms are less prevalent but can involve vascular inflammation. The document outlines signs, investigations, management approaches including steroids, and variable prognoses for the different ION types.
This document discusses the evaluation of the nasolacrimal system. It covers the history and anatomy of the system, classification of epiphora, diagnostic tests used to evaluate the system including anatomical tests like syringing and probing, functional tests like dye disappearance tests, and secretory tests like Schirmer's test. The document also discusses differentiating anatomical obstruction from functional/physiological causes of excessive tearing and localization of blockages in the system.
This document provides an overview of myopia, including its definition, global epidemiology, risk factors, management options, and the importance of controlling axial length growth. It discusses that myopia prevalence is increasing globally and poses lifelong risks. Risk factors for increased myopia progression include younger age, family history, near work, ethnicity, and binocular vision issues. The document reviews behavioral, optical, and pharmacological management strategies and their effectiveness, noting that controlling axial length growth through approaches like orthokeratology and atropine is key to managing myopia progression.
Pseudoexfoliation glaucoma is a type of secondary glaucoma caused by the buildup of fibrillar protein deposits in the eye. It is the most common cause of secondary glaucoma worldwide and can lead to rapid progression of optic nerve damage. Risk factors include being over 50 years old, female gender, and living in northern latitudes. Signs include white flake deposits on the iris and lens that obstruct aqueous outflow, raising intraocular pressure and risk of vision loss from glaucoma if not treated.
This document discusses the classification and management of exotropia. Exotropia is an outward deviation of the visual axis and can be classified as primary, consecutive, secondary, or residual. Primary exotropia is further classified as intermittent or constant. Intermittent exotropia is present when the deviation is intermittently manifest and can be further classified as intermittent distance exotropia or intermittent near exotropia. Conservative treatment includes orthoptic exercises and optical measures like prisms or tinted glasses. Surgical treatment, such as lateral rectus recession or resection procedures, may be considered if conservative treatment is insufficient to control the deviation.
Vitreous hemorrhage occurs when blood leaks into the vitreous cavity in the eye. It can be caused by abnormal blood vessels like those seen in proliferative diabetic retinopathy, tears or detachment of the retina, trauma, or tumors. Patients experience symptoms like decreased vision and floaters. Examination may reveal an absent red reflex or old yellow vitreal hemorrhage. Management depends on the underlying cause and includes observation, laser treatment if the retina can be visualized, vitrectomy if the view is obscured or treatment can't be delivered, and anti-VEGF drugs to reduce neovascularization until laser can be performed.
Retinitis pigmentosa is a slow degenerative, hereditary disease of the retina that involves the rods and cones. It typically appears as a recessive trait due to consanguinity of the parents. Patients experience night blindness in childhood, tunnel vision or central visual loss in middle age, and complete blindness in advanced age. Physical examination shows black spots resembling bone corpuscles across the retina, extremely attenuated retinal blood vessels, and pale optic discs, indicating optic nerve atrophy. There is no specific treatment currently available, but cataract surgery and rehabilitation services can help manage complications.
Intermittent exotropia is the most common form of divergent strabismus where one or both eyes drift outward intermittently from normal alignment. It typically onset before age 5 and manifests during periods of inattention, fatigue, or drowsiness. Treatment options include non-surgical methods like spectacle correction, patching the dominant eye, or base-in prisms, as well as surgical recession of the lateral rectus muscles to improve alignment if control is lost. The goal of treatment is to restore proper eye alignment and preserve binocular single vision.
This document discusses visual field testing and perimetry. It defines the visual field and describes common visual field defects. It then covers the indications, methods, and terminology of visual field testing. Specific details are provided on threshold testing strategies, reliability indices, and how to interpret visual field printout maps and global indices. Criteria for diagnosing glaucomatous visual field loss and detecting progression over time are also outlined.
This document provides guidelines for pediatric eye examinations across different age groups. It divides children into infants/toddlers (birth to 2 years 11 months), preschool (3 to 5 years 11 months) and school-age (6 to 18 years). Examination procedures are described for each age group, including visual acuity testing, refraction, binocular vision evaluation, ocular health assessment and more. The document emphasizes using age-appropriate techniques and establishing expected levels of visual function for pediatric patients. Key examination procedures are defined, such as cycloplegic retinoscopy, cover tests, stereopsis tests and others. Recommended examination frequencies are provided based on a patient's age and risk factors.
This document provides information on hereditary macular dystrophies and macular function tests. It begins by describing the anatomical landmarks of the macula, including the fovea and foveola. It then discusses psychophysical macular function tests such as visual acuity testing, color vision testing, photostress testing, and Amsler grid testing. The document also covers electrophysiological tests like electroretinography (ERG) which objectively measures retinal electrical activity in response to light. ERG testing analyzes the a-wave from photoreceptors and b-wave from bipolar cells.
- When a minus lens moves closer to the eye, it becomes stronger, and when it moves farther from the eye, it becomes weaker. Magnification and minification are also affected by vertex distance.
- The vertex compensation formula is used to calculate power changes when a lens moves closer or farther from the eye. The power adjustment is equal to the lens power squared divided by 1000, multiplied by the distance of movement in millimeters.
- The effective power of a lens varies with vertex distance and is calculated as the lens power divided by 1 minus the distance in meters multiplied by the power.
The document discusses visual field testing in glaucoma. It defines the visual field and perimetry, and describes the major types of clinical perimetry tests including full threshold, SITA standard, and SITA fast on Humphrey and normal, dynamic, and TOP strategies on Octopus. It explains parameters such as test patterns, reliability, age-corrected plots, tests like GHT and Bebie curve, and global indices including MD, PSD, SF, and CPSD. The purpose of visual field testing in glaucoma is to detect and monitor disease by measuring light sensitivity across the retinal field.
Various Soft Contact Lens- designs and their indications Urusha Maharjan
The document discusses various designs and material properties of soft contact lenses, describing 19 different types of soft contact lenses categorized by their water content, oxygen permeability, and FDA group. It provides details on common lens materials like polymacon, alphafilcon A, and etafilcon A as well as specific lenses from brands like Bausch & Lomb, Johnson & Johnson, and Ciba Vision. The document compares silicone hydrogel lenses to conventional hydrogel lenses and their differences in oxygen transmissibility and compatibility with care solutions.
Pigment dispersion syndrome involves the abnormal release of pigment from the iris that is deposited throughout the eye. Some patients may develop pigmentary glaucoma. The mechanical abrasion theory proposes that iris defects allow iris pigment to enter the eye. The abiotrophy theory suggests there is a genetic component. Symptoms are typically absent early on but later include vision loss. Signs include pigment deposition in tissues like the cornea and trabecular meshwork. Treatment focuses on lowering intraocular pressure through medications, laser trabeculoplasty, or surgery if needed. About 25-50% of patients may progress to pigmentary glaucoma.
Connective tissue diseases can involve the eyes and cause various inflammatory conditions. Rheumatoid arthritis is a common cause of scleritis and episcleritis, occurring in 4-10% of patients. Keratoconjunctivitis sicca (dry eyes) is the most common ocular manifestation of rheumatoid arthritis, affecting 10-35% of patients, mostly women. Scleritis may occur and can cause vision loss if not treated adequately with immunosuppressants. Keratitis can also occur from corneal thinning or ulceration. Systemic lupus erythematosus can also cause ocular inflammation and is more common in women.
This document provides guidelines for prescribing glasses in children. It defines various refractive errors such as myopia, hyperopia, and astigmatism. It recommends fully correcting refractive errors over ±4 diopters as these can cause amblyopia. For lower refractive errors, it recommends considering the child's age and visual needs. Anisometropia over 1.5 diopters should also be corrected. Special cases like accommodative esotropia may require bifocals. The goal of treatment is to provide a clear retinal image while maintaining proper accommodation and convergence.
This document discusses the effects of diabetes on the eye. It begins with an introduction to diabetes mellitus and its long-term damaging effects on organs. It then covers the two main types of diabetes and their characteristics. The document discusses the pathogenesis of diabetic retinopathy and how high blood glucose damages blood vessels in the eye. It provides a detailed overview of the stages of diabetic retinopathy from mild non-proliferative to proliferative and potential vision loss outcomes. Management strategies like glucose control, laser therapy, anti-VEGF drugs, and vitrectomy are summarized.
Pigment dispersion syndrome is characterized by the dispersion of pigment granules from the iris pigment epithelium throughout the anterior segment of the eye. This can lead to elevated intraocular pressure and pigmentary glaucoma. It typically affects young, myopic white males and is caused by rubbing of the iris pigment epithelium against the lens zonules due to posterior bowing of the peripheral iris. Diagnosis is based on finding the classic triad of Krukenberg spindle on the cornea, midperipheral iris transillumination defects, and dense trabecular pigmentation on gonioscopy.
Diabetic retinopathy is a leading cause of blindness worldwide. Prolonged hyperglycemia can damage retinal blood vessels and neurons. Over time, this can lead to vision loss through retinal edema, hemorrhage, fibrosis or neovascularization. Risk factors include duration and control of diabetes, hypertension, and nephropathy. Treatment focuses on laser photocoagulation and intravitreal injections to reduce edema or abnormal blood vessels, along with glycemic control to prevent progression. Regular screening is important to detect diabetic retinopathy early when treatment is most effective.
To know Humphrey visual field analyser
To know about various types of perimetry
To identify field defect
To recognize that field defect is due to glaucoma or neurological lesion
To know that field defect is progressive or not
Interpretation of HVFA
- Infantile esotropia refers to a large-angle, inward eye turning (esotropia) that develops before 6 months of age. It is characterized by limited eye movement outward (abduction) and may be caused by weakness of the sixth nerve or abnormal eye muscle development.
- Evaluation involves assessing eye alignment, eye movement, fixation, and refractive error. Treatment depends on the type and severity of esotropia but commonly includes eyeglasses, eye muscle surgery, Botox injections, or a combination of treatments. The goal is to align the eyes properly to prevent amblyopia.
This document summarizes a journal club presentation on a study investigating the safety and efficacy of lower doses (0.01%, 0.1%, and 0.5%) of atropine for treating childhood myopia. The study involved 400 children aged 6-12 years with myopia who were randomized to receive one of the three atropine doses nightly for 2 years. Results showed a dose-dependent response, with the 0.5% dose slowing myopia progression the most but also causing more side effects like diminished accommodation and larger pupils. The 0.01% dose had the smallest effect on slowing progression but caused minimal side effects. Overall, lower doses of atropine showed potential as an alternative treatment with fewer visual side
Diplopia charting involves recording the separation of double images seen by a patient in nine positions of gaze. The examiner uses a red glass over one eye while holding a light source in different positions. The patient reports if they see one image, two separate images, or a tilted image. The separation is greatest in the direction of an underacting or paralyzed eye muscle. When recording the results, the patient's right and left sides are noted along with the distance of any separation between images and any tilting. The diplopia chart should be interpreted along with a clinical exam and Hess chart.
The document discusses the diagnostic evaluation process for strabismus. It covers the classification of strabismus, including pseudostrabismus and true strabismus. It also describes tests used to evaluate visual acuity, sensory function, motor function, and stereopsis. These include cover tests, versions, ductions, and specialized tests like Hirschberg's test, Krimsky test, and Bruckner test. The goal of the evaluation is to accurately diagnose the type of strabismus and measure the ocular misalignment.
This document provides information on examining a case of strabismus. It begins with the author's disclosure statement and then is divided into sections on history, examination, equipment, motor status, sensory status, measurement of deviation, and special tests. The history section covers items like visual acuity, eye involvement, and medical history. Examination assesses areas such as head posture, ocular deviation, eye movements, and binocular vision status. Various tests and equipment used are also outlined.
Retinitis pigmentosa is a genetic disorder that causes the rods and cones in the retina to deteriorate over time. This leads to progressive vision loss starting with night blindness and loss of peripheral vision, which can eventually cause total blindness. There is no cure, but vitamin A supplementation and an omega-3 rich diet have been shown to potentially slow the progression of the disease. It is diagnosed through visual field tests and ERG testing, and patients are referred to low vision specialists who can prescribe aids to help maximize remaining vision.
This document discusses Retinitis Pigmentosa (RP), a group of inherited retinal disorders characterized by progressive dysfunction of rod photoreceptors and subsequent degeneration of cone photoreceptors. It causes night blindness and visual field loss. RP has several subtypes and can be inherited in autosomal dominant, recessive or X-linked patterns. Diagnosis involves visual field testing, electroretinography and fundus examination. There is no cure but vitamin supplements and low vision aids can help manage symptoms.
Intermittent exotropia is the most common form of divergent strabismus where one or both eyes drift outward intermittently from normal alignment. It typically onset before age 5 and manifests during periods of inattention, fatigue, or drowsiness. Treatment options include non-surgical methods like spectacle correction, patching the dominant eye, or base-in prisms, as well as surgical recession of the lateral rectus muscles to improve alignment if control is lost. The goal of treatment is to restore proper eye alignment and preserve binocular single vision.
This document discusses visual field testing and perimetry. It defines the visual field and describes common visual field defects. It then covers the indications, methods, and terminology of visual field testing. Specific details are provided on threshold testing strategies, reliability indices, and how to interpret visual field printout maps and global indices. Criteria for diagnosing glaucomatous visual field loss and detecting progression over time are also outlined.
This document provides guidelines for pediatric eye examinations across different age groups. It divides children into infants/toddlers (birth to 2 years 11 months), preschool (3 to 5 years 11 months) and school-age (6 to 18 years). Examination procedures are described for each age group, including visual acuity testing, refraction, binocular vision evaluation, ocular health assessment and more. The document emphasizes using age-appropriate techniques and establishing expected levels of visual function for pediatric patients. Key examination procedures are defined, such as cycloplegic retinoscopy, cover tests, stereopsis tests and others. Recommended examination frequencies are provided based on a patient's age and risk factors.
This document provides information on hereditary macular dystrophies and macular function tests. It begins by describing the anatomical landmarks of the macula, including the fovea and foveola. It then discusses psychophysical macular function tests such as visual acuity testing, color vision testing, photostress testing, and Amsler grid testing. The document also covers electrophysiological tests like electroretinography (ERG) which objectively measures retinal electrical activity in response to light. ERG testing analyzes the a-wave from photoreceptors and b-wave from bipolar cells.
- When a minus lens moves closer to the eye, it becomes stronger, and when it moves farther from the eye, it becomes weaker. Magnification and minification are also affected by vertex distance.
- The vertex compensation formula is used to calculate power changes when a lens moves closer or farther from the eye. The power adjustment is equal to the lens power squared divided by 1000, multiplied by the distance of movement in millimeters.
- The effective power of a lens varies with vertex distance and is calculated as the lens power divided by 1 minus the distance in meters multiplied by the power.
The document discusses visual field testing in glaucoma. It defines the visual field and perimetry, and describes the major types of clinical perimetry tests including full threshold, SITA standard, and SITA fast on Humphrey and normal, dynamic, and TOP strategies on Octopus. It explains parameters such as test patterns, reliability, age-corrected plots, tests like GHT and Bebie curve, and global indices including MD, PSD, SF, and CPSD. The purpose of visual field testing in glaucoma is to detect and monitor disease by measuring light sensitivity across the retinal field.
Various Soft Contact Lens- designs and their indications Urusha Maharjan
The document discusses various designs and material properties of soft contact lenses, describing 19 different types of soft contact lenses categorized by their water content, oxygen permeability, and FDA group. It provides details on common lens materials like polymacon, alphafilcon A, and etafilcon A as well as specific lenses from brands like Bausch & Lomb, Johnson & Johnson, and Ciba Vision. The document compares silicone hydrogel lenses to conventional hydrogel lenses and their differences in oxygen transmissibility and compatibility with care solutions.
Pigment dispersion syndrome involves the abnormal release of pigment from the iris that is deposited throughout the eye. Some patients may develop pigmentary glaucoma. The mechanical abrasion theory proposes that iris defects allow iris pigment to enter the eye. The abiotrophy theory suggests there is a genetic component. Symptoms are typically absent early on but later include vision loss. Signs include pigment deposition in tissues like the cornea and trabecular meshwork. Treatment focuses on lowering intraocular pressure through medications, laser trabeculoplasty, or surgery if needed. About 25-50% of patients may progress to pigmentary glaucoma.
Connective tissue diseases can involve the eyes and cause various inflammatory conditions. Rheumatoid arthritis is a common cause of scleritis and episcleritis, occurring in 4-10% of patients. Keratoconjunctivitis sicca (dry eyes) is the most common ocular manifestation of rheumatoid arthritis, affecting 10-35% of patients, mostly women. Scleritis may occur and can cause vision loss if not treated adequately with immunosuppressants. Keratitis can also occur from corneal thinning or ulceration. Systemic lupus erythematosus can also cause ocular inflammation and is more common in women.
This document provides guidelines for prescribing glasses in children. It defines various refractive errors such as myopia, hyperopia, and astigmatism. It recommends fully correcting refractive errors over ±4 diopters as these can cause amblyopia. For lower refractive errors, it recommends considering the child's age and visual needs. Anisometropia over 1.5 diopters should also be corrected. Special cases like accommodative esotropia may require bifocals. The goal of treatment is to provide a clear retinal image while maintaining proper accommodation and convergence.
This document discusses the effects of diabetes on the eye. It begins with an introduction to diabetes mellitus and its long-term damaging effects on organs. It then covers the two main types of diabetes and their characteristics. The document discusses the pathogenesis of diabetic retinopathy and how high blood glucose damages blood vessels in the eye. It provides a detailed overview of the stages of diabetic retinopathy from mild non-proliferative to proliferative and potential vision loss outcomes. Management strategies like glucose control, laser therapy, anti-VEGF drugs, and vitrectomy are summarized.
Pigment dispersion syndrome is characterized by the dispersion of pigment granules from the iris pigment epithelium throughout the anterior segment of the eye. This can lead to elevated intraocular pressure and pigmentary glaucoma. It typically affects young, myopic white males and is caused by rubbing of the iris pigment epithelium against the lens zonules due to posterior bowing of the peripheral iris. Diagnosis is based on finding the classic triad of Krukenberg spindle on the cornea, midperipheral iris transillumination defects, and dense trabecular pigmentation on gonioscopy.
Diabetic retinopathy is a leading cause of blindness worldwide. Prolonged hyperglycemia can damage retinal blood vessels and neurons. Over time, this can lead to vision loss through retinal edema, hemorrhage, fibrosis or neovascularization. Risk factors include duration and control of diabetes, hypertension, and nephropathy. Treatment focuses on laser photocoagulation and intravitreal injections to reduce edema or abnormal blood vessels, along with glycemic control to prevent progression. Regular screening is important to detect diabetic retinopathy early when treatment is most effective.
To know Humphrey visual field analyser
To know about various types of perimetry
To identify field defect
To recognize that field defect is due to glaucoma or neurological lesion
To know that field defect is progressive or not
Interpretation of HVFA
- Infantile esotropia refers to a large-angle, inward eye turning (esotropia) that develops before 6 months of age. It is characterized by limited eye movement outward (abduction) and may be caused by weakness of the sixth nerve or abnormal eye muscle development.
- Evaluation involves assessing eye alignment, eye movement, fixation, and refractive error. Treatment depends on the type and severity of esotropia but commonly includes eyeglasses, eye muscle surgery, Botox injections, or a combination of treatments. The goal is to align the eyes properly to prevent amblyopia.
This document summarizes a journal club presentation on a study investigating the safety and efficacy of lower doses (0.01%, 0.1%, and 0.5%) of atropine for treating childhood myopia. The study involved 400 children aged 6-12 years with myopia who were randomized to receive one of the three atropine doses nightly for 2 years. Results showed a dose-dependent response, with the 0.5% dose slowing myopia progression the most but also causing more side effects like diminished accommodation and larger pupils. The 0.01% dose had the smallest effect on slowing progression but caused minimal side effects. Overall, lower doses of atropine showed potential as an alternative treatment with fewer visual side
Diplopia charting involves recording the separation of double images seen by a patient in nine positions of gaze. The examiner uses a red glass over one eye while holding a light source in different positions. The patient reports if they see one image, two separate images, or a tilted image. The separation is greatest in the direction of an underacting or paralyzed eye muscle. When recording the results, the patient's right and left sides are noted along with the distance of any separation between images and any tilting. The diplopia chart should be interpreted along with a clinical exam and Hess chart.
The document discusses the diagnostic evaluation process for strabismus. It covers the classification of strabismus, including pseudostrabismus and true strabismus. It also describes tests used to evaluate visual acuity, sensory function, motor function, and stereopsis. These include cover tests, versions, ductions, and specialized tests like Hirschberg's test, Krimsky test, and Bruckner test. The goal of the evaluation is to accurately diagnose the type of strabismus and measure the ocular misalignment.
This document provides information on examining a case of strabismus. It begins with the author's disclosure statement and then is divided into sections on history, examination, equipment, motor status, sensory status, measurement of deviation, and special tests. The history section covers items like visual acuity, eye involvement, and medical history. Examination assesses areas such as head posture, ocular deviation, eye movements, and binocular vision status. Various tests and equipment used are also outlined.
Retinitis pigmentosa is a genetic disorder that causes the rods and cones in the retina to deteriorate over time. This leads to progressive vision loss starting with night blindness and loss of peripheral vision, which can eventually cause total blindness. There is no cure, but vitamin A supplementation and an omega-3 rich diet have been shown to potentially slow the progression of the disease. It is diagnosed through visual field tests and ERG testing, and patients are referred to low vision specialists who can prescribe aids to help maximize remaining vision.
This document discusses Retinitis Pigmentosa (RP), a group of inherited retinal disorders characterized by progressive dysfunction of rod photoreceptors and subsequent degeneration of cone photoreceptors. It causes night blindness and visual field loss. RP has several subtypes and can be inherited in autosomal dominant, recessive or X-linked patterns. Diagnosis involves visual field testing, electroretinography and fundus examination. There is no cure but vitamin supplements and low vision aids can help manage symptoms.
Retinoblastoma is a rare form of eye cancer that affects young children. It occurs when nerve cells in the retina develop genetic mutations causing uncontrolled growth. In about 40% of cases it is inherited from a parent with a faulty gene. Symptoms include a white pupil, eye misalignment, poor vision, and eye swelling/redness. Treatment aims to preserve the child's life, then vision, and minimize side effects. Options include thermotherapy, laser photocoagulation, and cryotherapy. Children also face risks of cancer recurrence or developing other cancers.
Retinitis pigmentosa is a group of hereditary retinal diseases characterized by progressive degeneration of photoreceptors. It begins with night blindness and peripheral vision loss and can progress to tunnel vision or legal blindness. Genetic mutations affecting photoreceptor structure and function or RNA splicing are responsible. On examination, bone spicule pigmentation, vascular attenuation, optic nerve pallor and RPE changes are seen. Diagnosis is confirmed by electroretinography showing photoreceptor dysfunction. There is currently no cure but management focuses on low vision aids, vitamins, and gene or stem cell therapies which are under investigation.
Retinitis pigmentosa and allied disordersShruti Laddha
Retinitis pigmentosa is a group of inherited retinal diseases characterized by progressive vision loss. It has a prevalence of 1 in 3500 people. The document discusses the various types of retinitis pigmentosa based on inheritance patterns and symptoms. It also summarizes the clinical features, investigations, management, and associated syndromes of retinitis pigmentosa.
This document summarizes various inherited retinal dystrophies, including:
1. Diffuse photoreceptor dystrophies like retinitis pigmentosa and Leber's congenital amaurosis, and macular dystrophies like Stargardt's disease, vitelliform macular dystrophy, and pattern dystrophy.
2. It then describes choroidal dystrophies like choroideremia, gyrate atrophy, and Sorsby fundus dystrophy.
3. Key features, pathogenesis, genetic causes, clinical findings, investigations, and management are outlined for each condition. Differential diagnoses are also provided to help distinguish between similar appearing dystrophies.
The document discusses RPE65, a protein critical for normal vision. Mutations in the RPE65 gene cause retinal diseases like Leber's congenital amaurosis type 2 and retinitis pigmentosa due to defects in the visual cycle. These diseases lead to progressive retinal degeneration and vision loss. The GCC region has a higher prevalence of RPE65 deficiency disorders due to consanguineous marriages increasing genetic disorders. Luxturna gene therapy is the only approved treatment but has a high cost, creating a potential market for emerging therapies to treat these diseases.
Retinal dystrophies can be divided into four groups: generalized photoreceptor dystrophies, macular dystrophies, generalized choroidal dystrophies, and hereditary vitreoretinopathies. Retinitis pigmentosa is the most common form of generalized photoreceptor dystrophy and is characterized by progressive vision loss starting with night blindness and constricting visual fields. It can be inherited in autosomal dominant, recessive or X-linked patterns. Other forms of generalized photoreceptor dystrophy discussed include atypical RP, cone dystrophy, and Bietti crystalline choreoretinal dystrophy.
Richard Trevino presented four cases involving posterior segment pathology:
1) A case of torpedo maculopathy with its characteristic appearance and no treatment required.
2) Multiple CHRPE-like lesions in a child, which can signal familial adenomatous polyposis requiring colonoscopy.
3) Recurrent branch retinal artery occlusions in a young woman, which may indicate Susac's syndrome and require hearing and MRI evaluation.
4) An isolated cotton wool spot in a woman on birth control pills, which led to discontinuing the pills and testing for conditions like diabetes, lupus, and Lyme disease that can cause vascular occlusions.
This document provides information on macular dystrophies. It begins with the anatomical landmarks of the macula including the fovea and foveola. It then discusses various hereditary macular dystrophies including X-linked juvenile retinoschisis, Stargardt's disease, Best's disease, dominant familial drusen, and pattern dystrophy. For each condition, it provides information on genetics, symptoms, signs, imaging findings, and management. The document uses images to illustrate many of the clinical features described.
This document discusses hereditary retinal dystrophies. It begins by introducing retinal dystrophies and classifying them based on inheritance pattern and the pathological process affected. Several specific dystrophies are then discussed in more detail, including retinitis pigmentosa, Stargardt disease, and Best vitelliform macular dystrophy. For each, the document outlines clinical features, inheritance patterns, investigations, treatment approaches, and complications. Overall, the document provides an overview of hereditary retinal dystrophies with a focus on several common genetic subtypes.
1. Retinitis pigmentosa is a genetically determined, progressive degeneration of retinal photoreceptors that affects both eyes symmetrically. It initially impacts rods, followed by cones.
2. Symptoms include night blindness, loss of peripheral vision, light sensitivity, and eventual loss of central vision. It can be inherited in autosomal recessive, autosomal dominant, or X-linked patterns.
3. Diagnosis involves visual acuity testing, visual fields, color vision, dilated fundus exam showing bone spicule pigmentation, attenuated vessels, and disc pallor. Electroretinography can detect early disease. There is no cure but vitamin supplementation and low-light lifestyle adaptations can
Retinitis pigmentosa is a genetically heterogeneous group of retinal disorders characterized by progressive loss of photoreceptors and retinal pigment epithelium. It is a common cause of visual impairment, affecting around 1 in 3000-5000 people. The disease typically begins with night blindness in adolescence or early adulthood due to rod photoreceptor degeneration, eventually progressing to include cone cell death and visual field constriction. Genetic testing can help determine the inheritance pattern and risk of transmission to family members. Further research aims to identify all disease-causing genes and mutations to improve molecular diagnosis and understanding of retinitis pigmentosa.
This document provides an overview of various retinal dystrophies presented by Dr. Farhad Uddin Ahmed. It discusses four main groups of retinal dystrophies: generalized photoreceptor dystrophies, macular dystrophies, generalized choroidal dystrophies, and hereditary vitreoretinopathies. Within each group, several specific conditions are described, including details on inheritance, symptoms, signs, investigations, and management. Retinitis pigmentosa is discussed as the most common generalized photoreceptor dystrophy. Stargardt disease and Best disease are two macular dystrophies highlighted.
Rods contain the visual pigment rhodopsin, which consists of the protein opsin bound to the chromophore retinal. Rhodopsin absorbs blue light at 500nm and allows rods to function in low light conditions. Rods are more numerous and sensitive to light than cones, allowing vision in dim environments. When shifting from light to dark, the processes of pigment regeneration and phototransduction take place over 30 minutes to restore night vision through the visual pigment rhodopsin in rods. Nyctalopia, or night blindness, can result from vitamin A deficiency or other causes that impair rod function.
This document discusses the case of a 30-year-old male patient named Ramesh who presented with defective vision since birth. On examination, he was found to have pale optic discs, attenuated blood vessels, chorioretinal atrophy in the macula, and pigmented bony spicules in the periphery of both eyes. Based on these findings, a provisional diagnosis of bilateral retinitis pigmentosa was made. The document then provides details on the classification, pathogenesis, diagnosis, management, and differentials for retinitis pigmentosa.
1) A 20-year-old boy presented with gradual decrease in night vision over 6 months. Examination revealed signs consistent with retinitis pigmentosa including bone-spicule pigmentation and waxy pale optic discs.
2) Retinitis pigmentosa is a hereditary retinal dystrophy where rod photoreceptor cells are initially and predominantly affected, followed by cone degeneration. It typically causes night blindness and progressive loss of peripheral vision.
3) There is no cure for retinitis pigmentosa. Treatment aims to slow progression and improve quality of life through low vision aids, vitamin supplements, and emerging therapies like gene and retinal prosthesis. Prognosis depends on inheritance pattern, with
Retinitis pigmentosa is rare heritable diseases which affect photoreceptor and make the patient unable to see normally in dimlight then loss of vision.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
The technology uses reclaimed CO₂ as the dyeing medium in a closed loop process. When pressurized, CO₂ becomes supercritical (SC-CO₂). In this state CO₂ has a very high solvent power, allowing the dye to dissolve easily.
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...Advanced-Concepts-Team
Presentation in the Science Coffee of the Advanced Concepts Team of the European Space Agency on the 07.06.2024.
Speaker: Diego Blas (IFAE/ICREA)
Title: Gravitational wave detection with orbital motion of Moon and artificial
Abstract:
In this talk I will describe some recent ideas to find gravitational waves from supermassive black holes or of primordial origin by studying their secular effect on the orbital motion of the Moon or satellites that are laser ranged.
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...Scintica Instrumentation
Targeting Hsp90 and its pathogen Orthologs with Tethered Inhibitors as a Diagnostic and Therapeutic Strategy for cancer and infectious diseases with Dr. Timothy Haystead.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
Immersive Learning That Works: Research Grounding and Paths ForwardLeonel Morgado
We will metaverse into the essence of immersive learning, into its three dimensions and conceptual models. This approach encompasses elements from teaching methodologies to social involvement, through organizational concerns and technologies. Challenging the perception of learning as knowledge transfer, we introduce a 'Uses, Practices & Strategies' model operationalized by the 'Immersive Learning Brain' and ‘Immersion Cube’ frameworks. This approach offers a comprehensive guide through the intricacies of immersive educational experiences and spotlighting research frontiers, along the immersion dimensions of system, narrative, and agency. Our discourse extends to stakeholders beyond the academic sphere, addressing the interests of technologists, instructional designers, and policymakers. We span various contexts, from formal education to organizational transformation to the new horizon of an AI-pervasive society. This keynote aims to unite the iLRN community in a collaborative journey towards a future where immersive learning research and practice coalesce, paving the way for innovative educational research and practice landscapes.
3. Retinitis pigmentosa
A group of chronic hereditary eye diseases
characterized by dark pigmentation and
gradual degeneration of photoreceptor cells in
the retina, causing visual impairment.
✘ General feature of RP:-
✘ Classic bone spiculing in the peripheral retina.
✘ Trouble seeing at night with tunnel vision.
✘ Retinitis pigmentosa is one of the most common
inherited diseases of the retina (retinopathies),
which affects roughly 1 in 4,000 people.
4. Photoreceptor cells
Retinal cells that absorb and convert light into electrical signals,
which eventually transmit to the brain, where they are processed into
the images we see. There are two types of cell present in retina.
✘ Rod cells: present on the outer regions of the retina, and allow us to see
in dim and dark light.
✘ Cone cells: reside in the central part of the retina, and allow us to see
fine visual detail and color.
6. ✘ Researchers have discovered over 100 genes which play essential role in the
structure and function of photoreceptor cells.
✘ A disease-causing mutation in one of these genes can send faulty messages
to retinal cells that cause their progressive degeneration and damage to
photoreceptor cells whch cause vision impairment with black pigments, a
condition known as RP.
✘ Which initially and mainly affects the rod photoreceptor Cells with
subsequent degeneration of the cones.
✘ First signs of RP in affected children can be seen as early as age 10, with
progression of the disease continuing throughout the individual's life. But
due to the involvement of so many genes, the progression and severity of
RP varies greatly for the individuals.
✘ Eventually, most individuals with RP will lose most of their sight but still
complete blindness is uncommon.
Cause and progression
7. ✘ Disruption of molecular chaperones and misfolding of rhodopsin
proteins, the pigment of the rod cell that plays an essential role in the
visual-transduction cascade that enables vision in low-light conditions,
gives rise to autosomal dominance forms of RP.
✘ More than 100 mutations have been identified in the RHO gene such as
Pro23His, which causes about 25% of the autosomal dominant form of
RP.
✘ Mutations in pre-mRNA splicing factors such as PRPF3, PRPF8, PRPF31
and PAP1 can cause autosomal dominant form of RP.
✘ A mutation on the USH2A gene causes 10–15% of all autosomal
recessive and a syndrome form of RP known as Usher's syndrome.
✘ RPGR and RP2 genes are 6 of 2 genes that cause the X-linked form of RP
in their mutated state.
Mutated gene
9. Being an inherited disorder RP can potentially affect another member of
the family.
✘ According to family history inheritance patterns of RP can be described as:-
✘ Simplex inheritance:- In 30-40% of all cases, RP affect a person without any
family history. This can result from de-novo mutation.
✘ Other cases of RP, where family history has been determined, fall into three
main categories depends on the location and type of mutated gene:-
✘ Gene present on autosomes:-
✘ Autosomal recessive inheritance.
✘ Autosomal dominant inheritance.
✘ Gene present on X chromosome:-
✘ X-linked inheritance.
10. Autosomal recessive
inheritance:-
✘ These types of inheritance pattern of RP have been
identified in at least 45 genes. It takes two copies of the
mutant gene to give rise to the disorder. Person with
single copy of mutated gene is unaffected carrier.
✘ Two unaffected individuals who are carriers of the same
RP-inducing gene mutation can produce offspring with:-
✘ 25% chance the child will have the disorder.
✘ 50% chance the child will be a unaffected carrier.
✘ 25% chance the child will be normal.
11. Autosomal dominant
inheritance
✘ In this kind of inheritance only one mutated copy of
gene in cell is sufficient to cause the disorder.
✘ Most people with autosomal dominant RP have an
affected parent and other family members with the
disorder.
✘ When a dominant gene mutation occurs in one of the
parents, there is a 50% chance that any children will
inherit this mutation and the disorder.
12. X-linked inheritance
✘ If the genes associated with X-linked retinitis pigmentosa are located on
the X chromosome disease shows X-linked inheritance.
✘ In males, one altered copy of the gene in each cell is sufficient to cause
the condition.
✘ In females, mutations usually have to occur in both copes of the gene to
cause the disorder.
✘ If the father is affected, all sons will be unaffected and all daughters will
be carriers. If the mother is the carrier:-
50% chance of having a son with the disorder
50% chance of having a daughter who is a carrier
✘ However, at least 20 percent of females who carry only one mutated copy
of the gene develop mild symptoms of retinal pigmentosa.
14. Symptoms
✘ Due to loss of rod cells:-
✘ Night blindness: when you cannot see anything in the dark which makes it
hard to adjust in darkness.
✘ Tunnel vision: Due to the gradual loss of rod cells people tend to lose more
of the peripheral visual field, developing tunnel vision.
✘ Development of bone spicules in the fundus.
✘ visual field:- the area of space that is visible at a given instant without
moving the eyes.
Non-syndromic RP usually presents a variety of the
following symptoms:
15.
16. ✘ Poor color separation: In later stages, cone degradation makes it
difficult to see different colors clearly.
✘ Loss of central vision: Some people also have problems with central
vision.
✘ Latticework vision (due to loss of peripheral vision).
✘ Photopsia; (blinking/swirling/shimmering lights).
✘ Photophobia: aversion to bright lights
✘ Macular edema; Swelling of retina.
✘ Loss of depth perception.
✘ Blurring of vision.
✘ Cataracts.
Symptoms
18. ✘ Ophthalmoscope: a tool that allows for a wider, clear view of the
retina. This typically reveals abnormal, dark pigment deposits that
streak the retina. These pigment deposits are in part why the
disorder was named retinitis pigmentosa.
✘ Visual field testing: it helps measure side vision and finds any blind
spots that may be developing.
✘ Genetic testing: It can also help determine the likely course or
severity of a disease and whether gene therapy to replace the faulty
gene may be helpful.
✘ Optical coherence tomography (OCT): it takes highly detailed
pictures of retina and help in diagnose RP and find out how it is
affecting your retina.
Fundus photo of RP patient
Normal photo of Fundus
Tools and techniques
19. ✘ An ERG measures the electrical response of the retinal photoreceptor
cells to photic stimulation.
✘ People with RP have a decreased electrical activity, reflecting the
declining function of photoreceptors.
✘ This test uses gold foil or a contact lens with electrodes attached. A flash
of light is sent to the retina and the electrodes measure rod and cone cell
responses.
Electroretinogram/ Electroretinography(ERG)
The basic waveform of ERG
20. The two components that are most often
measured are the a- and b-waves. The a-wave is
the first large negative component, followed by
the b-wave which is corneal positive and usually
larger in amplitude.
Electroretinogram
22. There is no known cure for retinitis pigmentosa.
✘ Due to involvement of over 100 genes there are so many forms of RP,
Which makes it difficult to predict how any one patient will respond to any
treatment.
✘ However, doctors are working hard to find few new treatment options
such as orientation and mobility training, light avoidance and/or the use
of low-vision aids to slow down the progression of RP.
✘ Such as;-
✘ Acetazolamide: This medication can ease swelling called macular edema
and improve your vision.
✘ Vitamin A palmitate: High doses (15,000 IU/day) of vitamin A palmitate
may slow down progression of the RP in adults a little each year.
✘ Sunglasses: To protect eyes from harmful ultraviolet rays that may speed
vision loss.
23. Research is also being conducted in areas such as gene therapy
research, transplant research, and retinal prosthesis.
✘ Gene therapy: -
✘ Since RP is usually the result of a defective gene, gene therapy can be
used to put healthy genes in damaged cell or tissue.
✘ Transplantation: -
✘ Transplantation of healthy retinal cells into sick retinas could be a
potential treatment of RP.
✘ But these treatments have not yet been considered as clinically safe and
successful.
Potential treatment
One type of RP, caused by mutation with a gene RPE65, can be treated.
24. Retinal implant: -
✘ A device called “artificial retina” or the ARGUS II, developed by Second
Sight, is a prosthetic device that functions in place of lost photoreceptor
cells and may be helpful for some patients with severe vision loss due to RP.
✘ It consists of a light-sensitive electrode that is surgically implanted into a
single eye and paired with glasses equipped with a camera. Images are
converted to electrical pulses that are sent to the retina.
26. ✘ Non-syndromic RP: when it occurs alone, without any other clinical
findings.
✘ Retinitis pigmentosa sine pigmento
✘ Retinitis punctata albescens
✘ Sector retinitis pigmentosa
✘ Leber congenital amaurosis
✘ Pigmented paravenous chorioretinal atrophy.
Type of RP
✘ Cone-rod dystrophy:- when cones degradation takes prior to rods, so
daylight and color vision are affected before night vision.
✘ Syndromic RP: with other neurosensory disorders, developmental
abnormalities etc.
27.
28. ✘ Sine pimento means without pigment.
✘ Absence or paucity of pigment
accumulation.
✘ May subsequently appear with time.
✘ Functional manifestations are similar to
typical RP.
Retinitis pigmentosa sine pigmento
29. ✘ Albescens means whitish.
✘ Scattered whitish-yellow spots, most
numerous at the equator, usually sparing
the macula, and associated with arteriolar
attenuation.
✘ Nyctalopia (night blindness) and
progressive field loss occur.
Retinitis punctata albescens
30. ✘ Bone spicule pigmentation in specific area
only.
✘ Mainly involvement of inferior quadrants
only.
✘ Progression is slow (many cases are
apparently stationary)
✘ Unilateral RP can also occur.
Sector retinitis pigmentosa
31. ✘ Usher syndrome: RP combined with deafness (congenital or
progressive).
✘ Kearns–Sayre syndrome (Ragged Red Fiber Myopathy): RP combined
with ophthalmoplegia, dysphagia, ataxia, and cardiac conduction
defects.
✘ Nephrotic syndrome: RP associated with Alport's syndrome .
✘ McLeod syndrome: RP is in association with muscular dystrophy or
chronic granulomatous disease.
✘ Bardet–Biedl syndrome: RP associated with hypogonadism.
✘ Other conditions include neurosyphilis, toxoplasmosis and Refsum's
disease.
Syndromic RP
32. ✘ Children with RP may benefit from low vision aids that maximize existing
vision.
✘ For example, there are special lenses that magnify central vision to expand
visual field and eliminate glare.
✘ Computer programs that read text are readily available.
✘ Portable lighting devices can adjust a dark or dim environment.
✘ Mobility training can teach people to use a cane or a guide dog,
✘ Eye scanning techniques can help people to optimize remaining vision.
✘ Once a child is diagnosed, he or she will be referred to a low vision
specialist for a comprehensive evaluation. Parents may also want to meet
with the child's school administrators and teachers to make sure that
necessary accommodations are put in place.
Living with RP